中关村：下属公司盐酸曲马多片通过一致性评价

Core Viewpoint - Beijing Huasu Pharmaceutical, a subsidiary of Zhongguancun, has received notification from the National Medical Products Administration that its product "Tramadol Hydrochloride Tablets" (50mg) has passed the consistency evaluation for generic drug quality and efficacy [1] Group 1: Company Developments - Beijing Huasu is the fourth company to pass the consistency evaluation, joining three other companies that have already received approval [1] - The project has incurred a total research and development cost of approximately 5.9 million yuan [1] Group 2: Market Impact - The successful evaluation is expected to enhance the competitiveness of the drug and positively impact the company's performance [1] - However, drug sales are influenced by various factors, leading to inherent uncertainties [1]